1. Home/
  2. Compounds/
  3. selumetinib:decitabine (4:1 mol/mol)

selumetinib:decitabine (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:decitabine (4:1 mol/mol)
PharmacoGx selumetinib:decitabine (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:decitabine (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ABO CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA TBC1D19 CTRPv2 pan-cancer AAC -0.17 5e-06
mRNA CTDSPL CTRPv2 pan-cancer AAC 0.19 5e-06
mRNA TCEAL4 CTRPv2 pan-cancer AAC -0.17 5e-06
mRNA MSRB3 CTRPv2 pan-cancer AAC -0.17 5e-06
mRNA GPX8 CTRPv2 pan-cancer AAC -0.2 5e-06
mRNA TMED7-TICAM2 CTRPv2 pan-cancer AAC -0.18 6e-06
mRNA GLTSCR2 CTRPv2 pan-cancer AAC 0.18 6e-06
mRNA TRIB2 CTRPv2 pan-cancer AAC 0.18 6e-06
mRNA DSE CTRPv2 pan-cancer AAC -0.17 7e-06
Download CSV